| http://www.w3.org/ns/prov#value | - The case is the latest skirmish in the ongoing battle between generic drug makers, who want to bring generic versions of brand-name drugs to market as soon as possible, and brand-name manufacturers, who want to maximize their profits by keeping the generics out of the market for as long as possible.
|
